@FiercePharma: J&J chief hopes missing drugs return by year's end. News | Follow @FiercePharma
> Valeant Pharmaceuticals has appointed CEO Michael Pearson as chairman of the board and extended his contract until February 2017. Report
> Novartis and Roche's Xolair, a medication used to treat asthma attacks caused by allergens such as pollen and dust mites, helped children overcome milk allergies, a small study showed. News
> Pozen filed a motion to prevent generic drugmaker Par Pharmaceutical from launching a copycat version of its migraine drug Treximet. Story
> GW Pharmaceuticals' pioneering cannabis drug Sativex has been recommended for approval in the six other European countries targeted by the British company and Spanish partner Almirall. Item
> Lonza has been awarded two contracts for biological drug candidates in quick succession, including a new deal that will make use of its large-scale U.S. biopharmaceutical facility in New Hampshire. Article
> A subsidiary of Watson Pharmaceuticals has launched a treatment for herpes infections. Story
Biotech News
@FierceBiotech: GSK's Witty: Development must be radically restructured in R&D revolution. Report | Follow @FierceBiotech
@JohnCFierce: Lilly's Lechleiter insists there will be no mega mergers for the 543rd time. Beijing report oddly misspells his name. Article | Follow @JohnCFierce
> Cephalon scoops up cancer drugs in $525M Gemin X buyout. News
> Bristol's breakthrough melanoma drug delivers promising data in Ph3. Item
> Peptimmune heads into bankruptcy after venture round fizzles. Article
Biotech Research News
> Shar-pei DNA reveals new wrinkle in fever disorders. Article
> TB protein discovery could lead to better vax. News
> UK, UMass stem cell banks join forces. Story
> Bluebird bio's gene therapy hits a high note. Report
Manufacturing News
> Little buzz for Obama's track/trace proposal. Item
> Industry lobbies for foreign plant inspections. Article
> USP, FDA update quality standards for common drugs. Report
> Genzyme: Fill/finish causes Thyrogen shortage. News
> Consent decree diminishes CEO Weldon's role in McNeil turnaround. Article
> FDA, EMA team on QbD-based joint reviews. Story
And Finally... A new test for human papillomavirus is just as sensitive as the old one, but more specific for detecting cervical cancer, meaning that it has fewer false positive results. Report